Home Newsfeeds JP Morgan Downgrades Trinet Group to Underweight, Announces $96 Price Target

JP Morgan Downgrades Trinet Group to Underweight, Announces $96 Price Target

JP Morgan analyst Tien-Tsin Huang downgrades Trinet Group (NYSE:TNET) from Neutral to Underweight and announces $96 price target.

byBenzinga Newsdesk

August 16, 2022

1 minute read

JP Morgan analyst Tien-Tsin Huang downgrades Trinet Group (NYSE:TNET) from Neutral to Underweight and announces $96 price target.

What’s Going On With TaskUs Stock Today?

By Anusuya Lahiri

November 8, 1:59 PM

RBC Capital analyst Daniel Perlin reiterated Outperform on TaskUs, Inc (NASDAQ:TASK) with a $26 price target after the company reported Q3 earnings beat.…

TASK

Exane BNP Paribas Initiates Coverage On Qorvo with Neutral Rating

By Benzinga Newsdesk

September 13, 7:31 AM

Exane BNP Paribas analyst Karl Ackerman initiates coverage on Qorvo (NASDAQ:QRVO) with a Neutral rating.

QRVO

Why Upstart And Other Lending Stocks Are Catching Bids Today

By Adam Eckert

August 3, 11:05 AM

Upstart Holdings Inc (NASDAQ: UPST) shares are trading higher Wednesday, in sympathy with SoFi Technologies Inc (NASDAQ: SOFI), which reported better-than-expected financial results and raised full-y

Reported Late Tuesday Feb. 28, Travere Therapeutics Announces Pricing Of $200M Upsized Public Offering Of 8.275M Shares Of Common Stock At A Price Of $21/Share And 1.25M Pre-Funded Warrants

By Happy Mohamed

March 1, 1:38 AM

Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced the pricing of an underwritten public offering of 8,275,000 shares of its common stock at a price to the public of $21.00 per share and, in lieu of

TVTX

JP Morgan Downgrades Trinet Group to Underweight, Announces $96 Price Target

Related Posts

What’s Going On With TaskUs Stock Today?

Exane BNP Paribas Initiates Coverage On Qorvo with Neutral Rating

Why Upstart And Other Lending Stocks Are Catching Bids Today

Reported Late Tuesday Feb. 28, Travere Therapeutics Announces Pricing Of $200M Upsized Public Offering Of 8.275M Shares Of Common Stock At A Price Of $21/Share And 1.25M Pre-Funded Warrants